Drug Profile
BCWP E004
Alternative Names: BCWP-E004Latest Information Update: 28 Aug 2020
Price :
$50
*
At a glance
- Originator BC World Pharm
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Benign prostatic hyperplasia
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for research development in Benign-prostatic-hyperplasia in South Korea (PO, Controlled release)
- 11 Jul 2016 Early research in Benign prostatic hyperplasia in South Korea (PO)